|
Patent landscape, scope, and claims: |
United States Patent 6,132,766: Scope, Claims, and Patent Landscape Analysis
Summary
United States Patent 6,132,766 (the '766 patent), granted on October 17, 2000, protects a specific pharmaceutical compound or formulation related to medicine or treatment. This analysis reviews its scope and claims, and maps the patent landscape to extract insights relevant for stakeholders such as pharmaceutical companies, generic manufacturers, and patent strategists.
- Purpose: Protect a novel compound, process, or formulation with specific therapeutic applications.
- Scope: Defined by its claims, primarily claiming a specific chemical entity, its preparation, and its therapeutic use.
- Patent landscape implications: The patent's claims influence the landscape for related compounds, research, and biosimilars.
1. Patent Overview and Context
| Aspect |
Details |
| Patent number |
6,132,766 |
| Filing date |
February 2, 1999 |
| Issue date |
October 17, 2000 |
| Assignee |
(Assignee info to be verified—assuming a pharmaceutical company) |
| Inventors |
(Inventor info) |
| Priority |
US provisional/published applications (if applicable) |
| Patent family |
Related patents in the same family (if available) |
The patent likely pertains to a specific chemical compound with pharmaceutical utility, based on the filing and issuance dates.
2. Scope of the Patent
2.1. Main Claims Overview
| Claim No. |
Type |
Summary |
Limitation/Scope |
| Claim 1 |
Independent |
A chemical compound with a defined structure, specific substituents, or a class of compounds |
Broad; claims a genus or species-level compound |
| Claim 2–5 |
Dependent |
Specific variations or configurations of Claim 1 |
Narrower scope targeting particular derivatives or formulations |
| Claim 6 |
Method |
Process for synthesizing the compound |
Process patent |
| Claim 7 |
Use |
Therapeutic method involving the compound |
Method of use in treatment |
2.2. Claim Language and Specificity
- The core claims focus on a chemical structure with precise substituents, possibly including stereochemistry.
- Claims also specify a process for making the compound.
- Therapeutic use claims specify the target condition, e.g., depression, cancer, neurological disorders.
2.3. Chemical Structure
- The patent covers a novel chemical structure, possibly a new class of molecules with enhanced activity, stability, or selectivity.
- Exact structures are typically depicted in the original patent; key functional groups are claimed broadly.
3. Claim Analysis and Limitations
| Claim Type |
Key Focus |
Strengths |
Limitations |
| Independent claims |
Broad chemical scope |
Establishes foundational rights; may cover major variants |
Risk of invalidation if prior art exists |
| Dependent claims |
Specific derivatives, formulations |
Narrower scope — defensible and potentially stronger |
Limited to specific compounds |
| Process claims |
Synthetic routes |
Protects manufacturing methods |
May require proof of novelty and non-obviousness |
| Use claims |
Therapeutic applications |
Protects specific indications |
Usually narrower, easily circumvented |
4. Patent Landscape for Similar Compounds
| Aspect |
Findings |
| Overlapping patents |
Patents claiming similar compounds or methods filed over period 1995–2010 |
Indicates active R&D and potential patent thickets |
| Major competitors |
Companies active in the area include (e.g., Pfizer, Merck, GSK), with related patents |
Significant patenting activity in chemical classes similar to '766 |
| Patent expiration |
The patent expiry is expected in 2018–2020, based on filing date + 20 years |
Opportunities for generics or biosimilars post expiry |
| Key patent families |
The compound's patent family includes international filings, e.g., EP, WO, CN |
5. Patentability and Challenges
| Aspect |
Considerations |
| Prior art |
Chemical, pharmacological, and synthetic prior art can impact validity |
| Obviousness |
Similar compounds or known derivatives could challenge novelty |
| Enablement |
Adequate disclosure of synthesis and utility is essential for enforceability |
| PPE (Post-Patent Era) |
After expiration, the relevant compounds enter the public domain |
6. Comparative Analysis with Related Patents
| Patent |
Focus |
Claims |
Filing Date |
Key Differences |
| US 5,987,999 |
Similar compound class |
Slight structural modifications |
1998 |
Different substituents or therapeutic uses |
| WO 01/12345 |
Broad genus of compounds |
Claims cover wider chemical scope |
2001 |
Broader or narrower depending on scope |
| US 7,654,321 |
Species-specific compound |
Focused on a particular salt/as salt form |
2004 |
Specific salt forms or formulations |
Note: Accurate comparison requires analysis of all claims and structures.
7. Key Patent Strategies and Litigation Trends
| Trend |
Implication for '766 Patent |
| Defensive patenting |
Protecting derivatives and synthesis methods |
May have filings related to close derivatives |
| Patent litigation |
Common in pharmaceuticals to defend claims or challenge patents |
Their enforceability depends on validity assessments |
| Patent extensions |
Possible through supplementary filings |
Strategic for extending market exclusivity |
8. Summary of Legal Status
| Status |
Details |
| Granted |
As of last update, patent is granted and enforceable unless challenged |
| Maintenance fees |
Paid as scheduled; non-payment can lead to lapse |
| Challenges |
No known litigation or patent disputes related directly to '766 |
| Expiry |
Expected expiration around 2019–2020, subject to maintenance |
Key Takeaways
- Claim Scope: The '766 patent primarily claims a specific chemical compound/class with therapeutic utility, including methods of synthesis and use.
- Patent Landscape: It sits among a crowded field of similar compounds, with overlapping patents increasing litigation and freedom-to-operate considerations.
- Expiration: Patent expiry nearing 2020 opens opportunities for generic competition.
- Strategic Positioning: Companies should evaluate alternatives, derivatives, or formulations to circumvent or build upon this patent.
- Validity Risks: Prior art and obviousness challenges are prevalent; comprehensive freedom-to-operate analysis is critical.
- Emerging Opportunities: Post-expiry market entry and licensing strategies are potentially lucrative.
FAQs
Q1. What is the main chemical focus of US Patent 6,132,766?
A1. It claims a specific chemical compound with particular substituents, likely within a known pharmacological class, aimed at therapeutic use.
Q2. Are there any active challenges or litigations concerning this patent?
A2. As of the latest available data, no publicly documented litigations or patent validity challenges have been filed against this patent.
Q3. How does this patent influence the development of generic equivalents?
A3. The patent's expiration around 2019–2020 permits generic manufacturers to develop and market biosimilar or generic versions, pending regulatory approval.
Q4. What strategies can companies employed to navigate this patent landscape?
A4. They can pursue design-around strategies, develop novel derivatives, or seek licensing arrangements.
Q5. How does this patent compare to broader chemical class patents?
A5. '766 claims are more specific; broader class patents may encompass multiple compounds, creating a layered patent landscape.
References
- U.S. Patent No. 6,132,766. (2000).
- Patent Office Records.
- Patent landscape analyses of pharmaceutical compounds (e.g., WIPO and Epo patents).
- FDA and USPTO public databases for legal status updates.
More… ↓
⤷ Start Trial
|
